药物输送
癌症治疗
血液循环
全身循环
医学
生物相容性
癌症
药品
体内
癌症治疗
纳米技术
药理学
材料科学
生物
生物技术
内科学
传统医学
冶金
作者
Bijay Singh,Samir Mitragotri
标识
DOI:10.1016/j.biotechadv.2019.01.006
摘要
Clinical translation of nanoparticle drug (nanodrug) delivery systems for cancer therapy is primarily hindered by short half-life of nanodrugs in blood circulation and their poor ability of tumor targeting and penetration in vivo. Circulatory cells have garnered much attention in cancer therapy as drug delivery vehicles due to their biocompatibility, high mobility, biodegradability, tissue targeting capability, high drug loading capacity, ability to cross biological barriers and inherent ability to remain in blood circulation long enough to accumulate within the tumors. Here, we review the progress and potential of circulatory cells as nanodrug delivery vehicles, especially for cancer therapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI